Felzartamab
299IG301
Phase 3 small_molecule active
Quick answer
Felzartamab for Immunoglobulin A Nephropathy (IgAN) is a Phase 3 program (small_molecule) at Biogen with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Biogen
- Indication
- Immunoglobulin A Nephropathy (IgAN)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active